Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Erythropoietin (Primary)
- Indications Optic neuritis
- Focus Therapeutic Use
- Acronyms TONE
- 11 Oct 2017 Planned End Date changed from 1 Sep 2019 to 1 Oct 2019.
- 11 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Apr 2018.
- 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.